semaj83/ctmatch_classification huggingface dataset:
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Pregnancy Complications Weight Gain Healthy pregnant females > 18 years of age with singleton pregnancies (either nulliparous or multiparous) less than 15 weeks gestation a pre pregnancy BMI < 40 kg/m2 (owing to the fact that severe obesity with BMI> 40 may have limitations with respect to physical activity) plans to deliver at a Hamilton or London regional hospital or by home birth and willing to attend research visits at the community site where they were recruited able to tolerate dairy foods approval of primary care provider able to provide signed informed consent  unable to understand some English type 1 or type 2 diabetes breastfeeding during current pregnancy pregnancy resulting from in vitro fertilization known contraindications to exercise as recommended by the Canadian clinical practice guidelines for pregnancy severe gastrointestinal diseases or conditions any significant heart, kidney, liver or pancreatic diseases pre-existing diabetes currently smoking a depression score above 10 on the validated Edinburgh depression questionnaire
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-35.0,  Retinal Oxygenation Retinal Blood Flow Men and women aged between 18 and 35 years Nonsmokers Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant Normal laboratory values unless the investigator considers an abnormality to be clinically irrelevant Normal ophthalmic findings, ametropy < 3 Dpt  Regular use of medication, abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study (except oral contraceptive) Symptoms of a clinically relevant illness in the 3 weeks before the first study day Presence of any form of anemia Blood donation during the previous 3 weeks Pregnancy
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Deep Vein Thrombosis Pulmonary Embolus ≥ 18 years Investigator judges caval filtration clinically indicated for prevention of pulmonary embolism in patient with venous thromboembolic disease or at high risk for venous thromboembolic disease. Patient must meet at least one of the following Anticoagulant therapy is contraindicated, has failed, cannot be achieved or maintained, must be interrupted, resulted in complication, or places the patient at high risk of complication and the patient has Pulmonary embolus Iliocaval deep vein thrombosis (DVT) Severe trauma with high risk of venous thromboembolism including closed head injury, spinal cord injury, or multiple long bone or pelvic fractures Surgery planned with high risk of venous thromboembolism including procedures such as bariatric, orthopedic, or pelvic surgery Past history of thromboembolic disease undergoing surgery Therapeutic anticoagulation can be achieved, but the patient has Venous thromboembolism such as pulmonary embolism or DVT with limited cardiopulmonary reserve  Condition that inhibits radiographic visualization of the IVC Known inadequate venous anatomy to allow insertion or retrieval of the filter from the IVC including occlusion of the SVC or jugular veins Known IVC transverse diameter at target implant site > 28 mm Known obstructing abdominal mass or anatomy that is not suitable for infra-renal placement of IVC filter Known duplication of IVC or left-sided IVC Severe kyphosis or scoliosis Known IVC thrombosis extending to renal veins, or renal or gonadal vein thrombosis Risk for septic pulmonary embolism Confirmed bacteremia Estimated Glomerular Filtration Rate (eGFR) < 30 ml/min, or dialysis dependent
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-50.0,  Deep Venous Thrombosis Pulmonary Embolism Age: 18 years or older, and Pregnancy confirmed by urinary pregnancy test, and Gestational age < 14 weeks, and Previous objectively confirmed VTE, either unprovoked, in the presence of use of oral contraceptives or estrogen/progestagen use, or related to pregnancy or the postpartum period, or minor risk factors (e.g. long distance travel, minor trauma)  Previous VTE related to a major provoking risk factor (e.g. surgery, major trauma or plaster cast immobilisation in the 3 months prior to VTE) as the sole risk factor, or Indication for treatment with therapeutic dose anticoagulant therapy (e.g. treatment of acute VTE; permanent use of therapeutic anticoagulants outside of pregnancy), or Inability to provide informed consent, or Any contraindication listed in the local labelling of LMWH
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 0.0-6.0,  Transient Tachypnea of the Newborn Late preterm and term infants (post-menstrual age ≥ 34 weeks) delivered by cesarean section or vaginal delivery Diagnosis of TTN Parents signed informed consent  Meconium aspiration syndrome Respiratory distress syndrome Congenital heart disease Non respiratory disorders causing tachypnea
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Chronic Obstructive Pulmonary Disease chronic obstructive pulmonary disease (COPD), GOLD grade 2-3 residents at low altitude (<800 m)  Unstable condition, COPD exacerbation Mild (GOLD 1) or very severe COPD (GOLD 4) requirement for oxygen therapy at low altitude residence hypoventilation pulmonary hypertension more than mild or unstable cardiovascular disease use of drugs that affect respiratory center drive internal, neurologic or psychiatric disease that interfere with protocol compliance including current heavy smoking (>20 cigarettes per day), inability to perform 6 min walk test previous intolerance to moderate altitude (<2600m) Exposure to altitudes >1500m for >2 days within the last 4 weeks before the study
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Multiple Pulmonary Emboli Patients referred for CT pulmonary angiogram to pulmonary embolus  Class 3 or 4 Congestive Heart Failure Supraventricular tachycardia History of contrast allergy Unable to give informed consent Patients with serum creatinine >1.28 mg/dl without referring physician approval
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 0.462-0.846,  Respiratory Distress Syndrome, Newborn Bronchopulmonary Dysplasia Ventilator Induced Lung Injury Infants at 24-36 weeks corrected gestational age Already ventilated with high frequency ventilation Requiring FiO2=21%-70% to maintain adequate oxygen saturation Clinical stable o i.e. ventilated on current settings for more than just a few hours with stable but not necessarily normalized blood gases or transcutaneous values and oxygen requirement Parent(s) or guardian able and willing to provide informed consent  Major congenital cardiovascular or respiratory abnormalities The attending neonatologist responsible for the baby considers one of the ventilation modes unsuitable for the infant Poor skin integrity precluding use of transcutaneous monitoring Lack of parental signed written informed consent Parents under 18 years of age
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 0.462-0.577,  Premature Birth Parental consent 0 to 30+0 weeks(agreed dates) gestation born alive Breathing spontaneously at birth or soon after with minimal resuscitation Oxygen saturations >90% by 5 minutes  No parental consent Born in poor condition and unlikely to survive Needing resuscitation including intubation and/or chest compressions Not breathing and thus needing intubation Oxygen saturations <90% by 5 minutes <24 weeks gestation >30 weeks gestation
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Pregnancy aged 18 or above first-time parents able to speak and read the Chinese language; and Hong Kong residents  couples with past or family psychiatric history
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-32.0,  Vitamin A Deficiency Pregnant women >-18 years of age with low-risk obstetric  Pregnant women expecting a multiple birth Take vitamin A supplements during postpartum apart from study intervention Premature birth Newborn babies with birth defects and / or other serious diseases
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 0.0-0.164,  Infant Development Full-term newborns (>37 weeks and <41 weeks gestation) Adequate birth weight for his gestational age (between 3-97 percentiles) age: from 0 to 2 months (60 days) Maximum 30 days of exclusive breastfeeding From 30 days on, exclusive or >70% infant formula Normal Apgar score: 7-10 Umbilical pH ≥ of 7.10 Availability to continue during the whole study period Informed consent signed ( parent/legal representative)  Participating in other studies Nervous system disorders (hydrocephalic, perinatal hypoxia, intraventricular hemorrhage, neonatal meningitis, septic shock, West Sd...) Gastrointestinal disorders (cow's milk protein allergy, lactose intolerance) Mother's disease history or during pregnancy: neurological and metabolic diseases, diabetes mellitus type 1, hypothyroidism, undernutrition, infections TORCH complex Mothers receiving anxiolytic or antidepressant treatment during pregnancy or other potentially harmful drug treatments for infants' neurodevelopment Infant currently participating in another clinical study Infant's family who in the investigators assessment cannot be expected to comply with the protocol
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Precapillary Pulmonary Hypertension Interstitial Lung Disease Precapillary pulmonary hypertension, or interstitial lung disease New York Heart Association class 2-3 Residence at low altitude (<800m)  Unstable or exacerbated condition Very severe pulmonary hypertension or interstitial lung disease, New York Heart Association class 4 requirement for oxygen therapy at low altitude residence hypoventilation more than mild or unstable cardiovascular disease use of drugs that affect respiratory center drive internal, neurologic or psychiatric disease that interfere with protocol compliance including current heavy smoking (>20 cigarettes per day), inability to perform 6 min walk test previous intolerance to moderate altitude (<2600m) Exposure to altitudes >1500m for >2 days within the last 4 weeks before the study Pregnant or nursing patients
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Postpartum Depressive Mood Postpartum Sexual Function 45 year old women who desire contraception postpartum for at least 6 weeks 45 year old women who choose not to use oral contraceptive medication postpartum for at least 6 weeks for the control group  (Medication groups) Breastfeeding (although this may limit participant enrollment, combined oral contraceptives are contraindicated in this population) Delivery by cesarean section Previous history of depression, mood disorders, or psychiatric disorders Any condition (history or presence of) which contraindicates the use of combination OCs, including Thrombophlebitis or thromboembolic disorders, known or suspected clotting disorders, deep vein thrombosis, thrombogenic valvulopathies or rhythm disorders Pulmonary Embolism Cerebrovascular or coronary artery disease or myocardial infarction Diabetes mellitus Migraine headaches with focal, neurological symptoms
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-50.0,  Pregnancy Breastfeeding Contraception Cervical Cancer Postpartum Depression Age 18 or above at time of delivery Delivery of live born infant at estimated gestational age (EGA) ≥37wk Postpartum primiparous patients within the first 48 hours after delivery Patient intent to breastfeed Breastfeeding initiated within the first 48 hours of delivery and/or prior to hospital discharge (whichever occurs first) Infant is continuously rooming in with mother from the time of delivery English-speaking Able to read and complete surveys No anticipated discharge from military system, Tricare benefits, or move planned in the upcoming 6 months Willing to render informed consent  Patients delivered by the Family Medicine Department (relatively small number in our population who are not followed postpartum by the Department of Obstetrics and Gynecology) Any condition deemed by patient provider to be an absolute contraindication to breastfeeding Maternal HIV/AIDS Planned use of radioactive or chemotherapeutic medications or medication for other medical problems which is contraindicated for delivery Known fetal factor that would impair breastfeeding Fetal mid-facial defects Known fetal chromosomal abnormality Known fetal conditioning resulting in fetal hypotonia Labor and Delivery complications Maternal separation from infant during the first 48 hours postpartum (such as maternal ICU admission, infant NICU admission)
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Pregnancy Complicated by Cardiovascular Disorders as Postpartum Condition, Delivered During Previous Episode Breathing-Related Sleep Disorder Interval Contact Agreed to contact for future studies during nuMoM2b and not subsequently withdrawn from the cohort Have pregnancy outcome data from the nuMoM2b study At least 18 years of age (to begin interval contact attempts once nuMoM2b participant reaches age 18) Provision of verbal consent for telephone interview or acknowledgement of consent with completion of the web-based self-administered questionnaire In-clinic Visit Consented for participation in interval contacts and not subsequently withdrawn Between 2 and 3.5 years after the nuMoM2b pregnancy ended Self-report at least 6 months postpartum from any subsequent pregnancy Self-report not currently pregnant  Inability or refusal to provide informed consent for the study component
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Venous Thrombosis Pulmonary Embolism Lung Neoplasms Patient At least 18 years of age Either gender Diagnosed with resectable lung cancer or metastatic lung disease eligible to complete metastasectomy Undergoing one of the following surgeries: Segmentectomy, wedge resection, lobectomy, bilobectomy or pneumonectomy Competent to understand and sign consent documents Patient  Known allergic or anaphylactic reaction to contrast dye, heparin or low molecular weight heparin (LMWH) Under current anticoagulation for venous thromboembolism or other medical conditions Known renal impairment, defined as creatinine clearance value of less than 55ml/min/m2 as calculated by the Cockroft-Gault method History of, or ongoing liver disease, manifested as ascites or previous peritoneal tapping for ascites Pregnant or planning to become pregnant Diagnosed or treated for VTE in the past 3 months prior to surgery Present or previous increase risk of haemorrhage History of previous HIT (heparin induced thrombocytopenia) Platelet count must be below 75,000 Previously inserted Inferior Vena Cava Filter (IVC) filter
Patient description: A 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-50.0,  Postpartum Hemorrhage Elective cesarean delivery under spinal anesthesia Written informed consent to participate in this study Term pregnancy  Refusal to give written informed consent Allergy or hypersensitivity to carbetocin or oxytocin Conditions that predispose to uterine atony and postpartum hemorrhage, such as placenta previa, multiple gestation, preeclampsia, eclampsia, macrosomia, polyhydramnios, uterine fibroids, previous history of uterine atony and postpartum bleeding, or bleeding diathesis Hepatic, renal, and vascular disease